BIOCARTIS GROUP NV

BCART
Real-time Quote. Real-time  - 01/26 11:35:24 am
4.6EUR +0.88%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2019 2020
Net sales1 37,744,5
EBITDA1 -45,9-45,5
Operating profit (EBIT)1 -55,6-48,1
Operating Margin -147%-108%
Pre-Tax Profit (EBT)1 --57,3
Net income1 -64,1-56,7
Net margin -170%-128%
EPS2 -1,14-1,07
Dividend per Share --
Last update 03/05/2020-
1 EUR in Million
2 EUR
Estimates
Finances - Leverage
Fiscal Period: December 2019 2020
Net Debt1 -105
Net Cash position1 12,1-
Leverage (Debt / EBITDA) 0,26x-2,30x
Free Cash Flow1 -56,8-58,8
ROE (Net Profit / Equities) -74,6%-
Shareholders' equity1 85,9-
ROA (Net Profit / Asset) --
Assets1 --
Book Value Per Share --
Cash Flow per Share2 -0,97-0,88
Capex1 2,528,04
Capex / Sales 6,67%18,1%
Last update 03/05/202001/08/2021
1 EUR in Million
2 EUR
Estimates
Balance Sheet Analysis
Financial Ratios
Size 2020e 2021e
Capitalization 265 M € -
Entreprise Value (EV) 369 M € 430 M €
Valuation 2020e 2021e
P/E ratio (Price / EPS) -4,32x -4,42x
Capitalization / Revenue 5,95x 4,40x
EV / Revenue 8,30x 6,14x
EV / EBITDA -8,11x -8,25x
Yield (DPS / Price) - -
Price to book (Price / BVPS) - -
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) -108% -88,5%
Operating Leverage (Delta EBIT / Delta Sales) 0,76x -
Net Margin (Net Profit / Revenue) -128% -105%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) - -
Rate of Dividend - -
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   18,1% 13,4%
Cash Flow / Sales -114% -98,5%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) -2,30x -3,70x
Price Earning Ratio
EPS & Dividend